Aveanna Healthcare (NASDAQ:AVAH) Trading Down 3.4% - What's Next?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report)'s stock price was down 3.4% on Wednesday . The company traded as low as $5.40 and last traded at $5.34. Approximately 38,433 shares were traded during trading, a decline of 88% from the average daily volume of 334,191 shares. The stock had previously closed at $5.53.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th. UBS Group raised their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a report on Friday, May 9th.

Aveanna Healthcare Trading Up 2.2%

The stock has a market cap of $1.07 billion, a P/E ratio of -16.21 and a beta of 2.03. The firm has a 50-day simple moving average of $5.08 and a two-hundred day simple moving average of $4.94.

Insider Buying and Selling

In related news, major shareholder Paul R. Vigano sold 1,560,700 shares of the firm's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the sale, the insider now directly owns 29,640,756 shares of the company's stock, valued at $158,874,452.16. This trade represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the firm's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total value of $339,217.64. Following the completion of the sale, the insider now directly owns 1,453,948 shares in the company, valued at $8,011,253.48. This trade represents a 4.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,887,612 shares of company stock worth $26,269,057. Company insiders own 7.80% of the company's stock.

Institutional Trading of Aveanna Healthcare

Several large investors have recently bought and sold shares of AVAH. Jacobs Levy Equity Management Inc. boosted its stake in shares of Aveanna Healthcare by 50.1% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock valued at $2,437,000 after purchasing an additional 177,856 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Aveanna Healthcare by 11.3% during the fourth quarter. Northern Trust Corp now owns 478,907 shares of the company's stock valued at $2,189,000 after purchasing an additional 48,572 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Aveanna Healthcare by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock valued at $2,133,000 after purchasing an additional 4,047 shares in the last quarter. First Eagle Investment Management LLC acquired a new stake in shares of Aveanna Healthcare during the fourth quarter valued at about $1,992,000. Finally, Millennium Management LLC boosted its stake in shares of Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock valued at $1,830,000 after purchasing an additional 205,023 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.